117th OMICS Group Conference
International Conference on

Genetic Engineering & Genetically Modified Organisms

August 12-14, 2013 Raleigh-North Carolina, USA
Final Program
OMICS Group Conferences
Genetic Engineering-2013 Event
Conference Registration
Participants List from Academia

University of Texas at Arlington, USA

Stanford University School of Medicine, USA

Mahidol University, Thailand

Amirkabir University of Technology, Iran

Hamdard University, India

Yeshiva University, USA

University of Macau, China

Monash University, Australia

University of Michigan, Ann Arbor

Universidade Federal do Rio de Janeiro, Brazil

University of Denver, Colorado

University of Toronto, Canada

Zagazig University, Egypt

Banaras Hindu University, India

Taipei Medical University, Taiwan

University di Messina CNISM, Italy

University of Tasmania, Australia

Huazhong University of Science and Technology, China

Sogang University, Korea

University of Edinburgh, UK

Martin-Luther-University Halle-Wittenberg, USA

Universidade de Sao Paulo, Brazil

Eve University, Turkey

University of Delhi, India

Isfahan University of Technology(IUT), Iran

Taif University, Saudi Arabia

University Medical Center, Netherlands

University of Copenhagen, Denmark

University Paris, France

Participants List from Business

Cadila Pharmaceuticals, India

Chemical Works of Gedeon Richter, Hungary

3S-Pharmacological Consultation & Research GmbH, Germany

Royal Brisbane and Women's Hospital, Australia

Psoriasis and Cutaneous Inflammation Research Laboratory, USA

Alcon Laboratories Inc., USA

National Institute for Materials Science (NIMS), Japan

Grup de Recerca de Reumatologia (IRHVH), Spain

Bayer Health Care, Richmond, USA

Crown Bioscience Inc., China

Hammersmith Hospital, London

Van Drie Research LLC, USA

Dr.Reddy's labs, India

Merck Research Laboratories, USA

National Institute of Pharmaceutical Education and Research (NIPER), India

AstraZeneca R&D Boston, USA

Abbott Laboratories, USA

Hutchison MediPharma Limited, China

Sage Bionetworks, USA

Central Drug Research Institute, India

Glenmark Pharmaceuticals, India

National Institute for Interdisciplinary Science & Technology (NIIST), India

Novartis Campus, Austria

Day 1
Scientific Program
Day 2
Scientific Program
Day 3
Scientific Program
International Conference on Genetic Engineering & Genetically Modified Organisms, will be organized around the theme "The Power of Gene in turning Ordinary into Extraordinary."

Genetic Engineering-2013 is comprised of 18 tracks and 116 sessions designed to offer comprehensive sessions that address current issues in International Conference on Genetic Engineering & Genetically Modified Organisms.

Submit your abstract to any of the following tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.
Jim Sawitzke
National Cancer Institute,NIH
Tapan K. Bera
National Cancer Institute
Abstract Submission Register
Track 1: Bioethics & IPR
Track 1-1 Bioethics: The legal and socioeconomic impacts
Track 1-2 Intellectual property rights
Track 1-3 Patents & legal implications
Track 1-4 Biodiversity and farmers rights
Track 2: Biosafety and rDNA Guidelines
Track 2-1 Biosafety regulation and national and international guidelines
Track 2-2 r-DNA guidelines
Track 2-3 Experimental protocol approvals, levels of containment
Track 2-4 Roles of Institutional Biosafety Committee
Track 2-5 Safety control of genetic modification
Track 3: Gene and Cell Therapy using Mammalian Artificial Chromosome (MAC) Vectors
Track 3-1 MACs as novel gene delivery vectors
Track 3-2 MAC vectors for gene function studies
Track 3-3 MAC vectors for development of animal models
Track 3-4 Genetic defects and MAC-based therapy
Track 3-5 MAC in stem cell research
Track 3-6 MAC vectors for biotechnology
Track 3-7 MACs for cancer research
Track 4: Recombinant DNA Technology
Track 4-1 Restriction and modifying enzymes
Track 4-2 Design of linkers and adaptors
Track 4-3 Recombinant cytokines and antibodies
Track 4-4 Recombinant vaccines
Track 4-5 Recombinant growth hormones
Track 4-6 Recombinant therapeutic proteins
Track 4-7 Biological products through genetic engineering techniques
Track 4-8 Production of generic drugs using genetic engineering techniques
Track 5: Genetically Modified Products
Track 5-1 Method of production
Track 5-2 Regulation of the release of genetic modified organisms
Track 5-3 Genetically modified food controversies
Track 5-4 Risk analysis and assessment
Track 5-5 Functional food and chronic disease
Track 6: Human Genetic Engineering
Track 6-1 Human Genome Project (HGP)
Track 6-2 Evolutionary human genetics
Track 6-3 Human cloning & human genetic manipulation
Track 6-4 Genes and blood type
Track 6-5 Genes, inheritance and evolution
Track 6-6 Reproductive genetics
Track 6-7 In vitro fertilization & embryo transfer technology
Track 6-8 Genotype and phenotype
Track 6-9 Cytogenetic and genome research
Track 6-10 Human epigenetic disorders
Track 6-11 Xenotransplantation & organ donation
Track 6-12 Tissue engineering and its impacts
Track 7: Tools in Genetic Engineering
Track 7-1 Isolation and purification of nucleic acids
Track 7-2 Electrophoresis and types
Track 7-3 Blotting and types
Track 7-4 Polymerase Chain Reaction (PCR)
Track 7-5 Single cell analysis: genomics and functional genomics
Track 7-6 DNA sequencing
Track 7-7 Preparation of probes
Track 7-8 Different labeling methods
Track 7-9 Hybridization and types
Track 7-10 Radiography and chromatography techniques
Track 7-11 Particle bombardment, electroporation & microinjection
Track 8: Microbial Genetics
Track 8-1 Prokaryotic and eukaryotic gene expression
Track 8-2 Microbial DNA: Gene transfer
Track 8-3 Epigenetics in microorganisms
Track 8-4 Viral genetics
Track 8-5 Mutation: Changes to the genome
Track 9: Plant Genetic Engineering
Track 9-1 Plant genetics
Track 9-2 Transgenic plants
Track 9-3 Genetically modified crops & agriculture
Track 9-4 Cloning of plant DNA & cloning vectors
Track 9-5 Plant hormones & biotic stress
Track 9-6 Screening and selection of mutants
Track 9-7 Plant growth and life cycle, abiotic stress
Track 10: Genetic Engineering & Stem Cell Research
Track 10-1 Cell potency & toxicity screening
Track 10-2 Preclinical and clinical research
Track 10-3 Embryonic stem cell and adult stem cell
Track 10-4 Induced pluripotent stem cell
Track 10-5 Milk teeth stem cells
Track 10-6 Menstrual blood: Rich source of stem cells
Track 10-7 Stem cell for treating various diseases & syndromes
Track 11: Cloning and Techniques
Track 11-1 Vectors for cloning
Track 11-2 Mapping the DNA and DNA finger printing
Track 11-3 Chromosome walking and jumping
Track 11-4 Preparation of competent cell-transformation
Track 11-5 Gene Bank, genomic DNA library & cDNA libraries
Track 11-6 Cloning of animals & its impact on the environment
Track 11-7 Fish genetics
Track 11-8 Transgenic animals
Track 12: Genetics Syndromes and Genomics of Infectious Diseases
Track 12-1 Developmental genetics
Track 12-2 Cancer genetics
Track 12-3 Clinical genetics
Track 12-4 Genetic disorders and autoimmune diseases
Track 12-5 Genetics of host response and resistance to viruses
Track 12-6 Emerging infections & recent discoveries
Track 12-7 Pathogen genomic biology and therapy
Track 13: Genetic Engineering and Gene Therapy
Track 13-1 Vectors for gene therapy
Track 13-2 Molecular and cell mediated gene therapy
Track 13-3 Applications of gene therapy
Track 14: Neuroscience & Neurogenetics
Track 14-1 Neurogenetics of Psychiatric Disorders
Track 14-2 Clinical Neurology
Track 14-3 Neurobehavioral Genetics
Track 14-4 The Neurocognition of Genetic Disorders
Track 14-5 Neural Stem Cells
Track 14-6 Cognitive Neuroscience
Track 14-7 Genetic Brain Disorders
Track 14-8 Psychoneuroimmunology
Track 14-9 Neurogenomics & disease
Track 15: Cancer Genetics & Metabolism
Track 15-1 Insertional Mutagenesis Strategies in Cancer Genetics
Track 15-2 Clinical Cancer Genetics
Track 15-3 MicroRNA and Cancer
Track 15-4 Advances in Cancer Therapy
Track 15-5 Oncogenomics and Cancer Proteomics
Track 15-6 Oncogene and Cancer
Track 15-7 Role of Epigenetics in Cancer
Track 15-8 Advancements in Bioinformatics for Cancer Research
Track 15-9 Methods of Cancer Diagnosis, Therapy, and Prognosis
Track 15-10 Development of New Methods for Carcinogen/Mutagen screening
Track 16: Genetic Screening and Counseling
Track 17: Functional Genomics
Track 17-1 Personalized Medicine
Track 17-2 Pharmacogenomics & Pharmacokinetics
Track 17-3 RNAi Technology: Gene knockdown for Functional Genomics
Track 17-4 Epigenomics
Track 17-5 Metabolomics
Track 17-6 Predictive, Preventive and Personalised Medicine
Track 18: Genetics of Ageing
OMICS Group is a member of
   International Conferences   Scientific Conferences   Scientific Events    Scientific Conference    Conferences 2013   
Conference Secretariat: Genetic Engineering-2013, OMICS Group Conferences
McAfee SECURE sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams
5716 Corsa Ave., Suite 110, Westlake, Los Angeles, CA 91362-7354, USA | Tel: 1-650-268-9744 | Fax: 1-650-618-1414
Toll free: 1-800-216-6499 (USA & Canada), 1-800-651-097 (Australia)
Email: geneticengineering2013@omicsonline.us
Operated by Editors - Advancements in Genetic Engineering: Open Access, Gene Technology: Open Access and Human Genetics & Embryology: Open Access
The Organizers reserve the rights to make changes and adjustment to the information in this website
Copyright © 2013 OMICS Group Conferences - All rights reserved
Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version